Cas 254451-33-7,2-fluoro-4-(5-{[2-(3'-hydroxybiphenyl-2-yl)ethylamino]methyl}imidazol-1-ylmethyl)benzonitrile

254451-33-7

Post Buying Request

Basic information

Product Name: 2-fluoro-4-(5-{[2-(3'-hydroxybiphenyl-2-yl)ethylamino]methyl}imidazol-1-ylmethyl)benzonitrile
Synonyms: 2-fluoro-4-(5-{[2-(3'-hydroxybiphenyl-2-yl)ethylamino]methyl}imidazol-1-ylmethyl)benzonitrile
CAS NO:254451-33-7
Molecular Formula:
Molecular Weight: 426.493
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 2-fluoro-4-(5-{[2-(3'-hydroxybiphenyl-2-yl)ethylamino]methyl}imidazol-1-ylmethyl)benzonitrile(CAS DataBase Reference)
NIST Chemistry Reference: 2-fluoro-4-(5-{[2-(3'-hydroxybiphenyl-2-yl)ethylamino]methyl}imidazol-1-ylmethyl)benzonitrile(254451-33-7)
EPA Substance Registry System: 2-fluoro-4-(5-{[2-(3'-hydroxybiphenyl-2-yl)ethylamino]methyl}imidazol-1-ylmethyl)benzonitrile(254451-33-7)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 254451-33-7(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

254451-33-7 Suppliers

Recommended suppliers

254451-33-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 254451-33-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,5,4,4,5 and 1 respectively; the second part has 2 digits, 3 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 254451-33:
(8*2)+(7*5)+(6*4)+(5*4)+(4*5)+(3*1)+(2*3)+(1*3)=127
127 % 10 = 7
So 254451-33-7 is a valid CAS Registry Number.

254451-33-7Upstream product

254108-49-1 2-fluoro-4-[(5-formyl-1H-imidazol-1-yl)methyl]benzonitrile

254451-33-7Downstream Products

254451-33-7Relevant academic research and scientific papers

Inhibitors of prenyl-protein transferase

-

, (2008/06/13)

The present invention is directed to peptidomimetic macrocyclic compounds which inhibit prenyl-protein transferase and the prenylation of the oncogene protein Ras. The invention is further directed to chemotherapeutic compositions containing the compounds of this invention and methods for inhibiting prenyl-protein transferase and the prenylation of the oncogene protein Ras.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 254451-33-7